[HTML][HTML] Immune checkpoint inhibitors in thoracic malignancies: review of the existing evidence by an IASLC expert panel and recommendations
J Remon, F Passiglia, MJ Ahn, F Barlesi… - Journal of Thoracic …, 2020 - Elsevier
In the past 10 years, a deeper understanding of the immune landscape of cancers, including
immune evasion processes, has allowed the development of a new class of agents. The …
immune evasion processes, has allowed the development of a new class of agents. The …
[HTML][HTML] Thymoma and thymic carcinoma: Surgical resection and multidisciplinary treatment
Y Zhang, D Lin, B Aramini, F Yang, X Chen, X Wang… - Cancers, 2023 - mdpi.com
Simple Summary Surgery is the main treatment for thymic tumors, and multidisciplinary
treatment would benefit patients a lot. Despite numerous technological advances in the …
treatment would benefit patients a lot. Despite numerous technological advances in the …
Lenvatinib in patients with advanced or metastatic thymic carcinoma (REMORA): a multicentre, phase 2 trial
J Sato, M Satouchi, S Itoh, Y Okuma, S Niho… - The Lancet …, 2020 - thelancet.com
Background Thymic carcinoma is a rare malignant disease and standard treatment for
advanced or metastatic thymic carcinoma previously treated with platinum-based …
advanced or metastatic thymic carcinoma previously treated with platinum-based …
Lung and thymic carcinoids: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
E Baudin, M Caplin, R Garcia-Carbonero… - Annals of …, 2021 - annalsofoncology.org
The latest World Health Organization (WHO) classification from 2015 has grouped lung and
thymic neuroendocrine tumours (NETs)(named neoplasm in the digestive WHO …
thymic neuroendocrine tumours (NETs)(named neoplasm in the digestive WHO …
[HTML][HTML] Single-arm, multicentre, phase II trial of nivolumab for unresectable or recurrent thymic carcinoma: PRIMER study
Y Katsuya, H Horinouchi, T Seto, S Umemura… - European Journal of …, 2019 - Elsevier
Introduction Thymic carcinoma (TC) is a rare cancer with a poor prognosis and limited
treatment options, especially after relapse. Methods In this open-label, two-stage …
treatment options, especially after relapse. Methods In this open-label, two-stage …
[HTML][HTML] A high therapeutic efficacy of polymeric prodrug nano-assembly for a combination of photodynamic therapy and chemotherapy
X Yi, J Dai, Y Han, M Xu, X Zhang, S Zhen… - Communications …, 2018 - nature.com
Combination of photodynamic therapy and chemotherapy has been emerging as a new
strategy for cancer treatment. Conventional photosensitizer tends to aggregate in aqueous …
strategy for cancer treatment. Conventional photosensitizer tends to aggregate in aqueous …
[HTML][HTML] Thymic carcinomas—a concise multidisciplinary update on recent developments from the Thymic Carcinoma Working Group of the International Thymic …
AC Roden, U Ahmad, G Cardillo, N Girard… - Journal of Thoracic …, 2022 - Elsevier
Thymic carcinomas are rare malignancies that in general arise in the prevascular (anterior)
mediastinum. These tumors are usually invasive, often present at advanced stages, and …
mediastinum. These tumors are usually invasive, often present at advanced stages, and …
Comprehensive genomic profiling of 274 thymic epithelial tumors unveils oncogenic pathways and predictive biomarkers
N Girard, C Basse, A Schrock, S Ramkissoon… - The …, 2022 - academic.oup.com
Background Thymic malignancies represent a heterogeneous group of rare thoracic
cancers, which are classified according to the World Health Organization histopathologic …
cancers, which are classified according to the World Health Organization histopathologic …
[HTML][HTML] Systemic therapy in advanced thymic epithelial tumors: insights from the RYTHMIC prospective cohort
CM Du Vignaux, E Dansin, L Mhanna, L Greillier… - Journal of Thoracic …, 2018 - Elsevier
Abstract Introduction Thymic epithelial tumors (TETs) are rare malignancies that may be
aggressive and difficult to treat. In the advanced setting, systemic treatments may be …
aggressive and difficult to treat. In the advanced setting, systemic treatments may be …
Fatal adverse events in two thymoma patients treated with anti-PD-1 immune check point inhibitor and literature review
T Konstantina, R Konstantinos, K Anastasios… - Lung cancer, 2019 - Elsevier
Objectives Thymomas, as well as thymic carcinomas, are extremely rare tumors that arise
from the thymus. The management of these tumors is primarily the complete surgical …
from the thymus. The management of these tumors is primarily the complete surgical …